Voyager Therapeutics Appoints Nathan Jorgensen as CFO

Seeking AlphaJun 13 07:22 ET

Express News | Vor Biopharma Inc - Board Designated Robert Ang as Company's Interim Principal Financial Officer

ReutersJun 10 16:07 ET

Express News | Vor Biopharma Inc - on June 4, 2024, Nathan Jorgensen Notified Co of His Resignation as Chief Financial Officer of Company, Effective as of June 21

ReutersJun 10 16:07 ET

Vor Biopharma(VOR.US) Officer Sells US$20,356.55 in Common Stock

$Vor Biopharma(VOR.US)$ Officer Attar Eyal C. sold 14,645 shares of common stock on Jun 3, 2024 at an average price of $1.39 for a total value of $20,356.55.Source: Announcement What is statement of c

moomoo NewsJun 4 18:52 ET

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of June 1, 2024, the Compensation

Vor BiopharmaJun 4 00:00 ET

Buy Rating Affirmed for Vor Biopharma Amid Promising Clinical Trials and Market Potential Expansion

TipRanksMay 15 08:17 ET